The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor's biology and their translational

Margherita Luongo1, Pasqualina Laurenziello1, Giuseppe Cesta1

  • 1Laboratory of Preclinical and Translational Research, IRCCS CROB Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (PZ), 85028, Italy.

Molecular Cancer
|August 22, 2024
PubMed

Insights

Exosomes, tiny vesicles carrying non-coding RNAs, facilitate cancer cell communication. This study explores their role in sarcoma subtypes, highlighting potential diagnostic and therapeutic applications.

Area of Science:

  • Biomedical Sciences
  • Molecular Biology
  • Cancer Research

Background:

  • Exosomes are key mediators of intercellular communication, transporting biomolecules like non-coding RNAs.
  • Non-coding RNAs within exosomes play a crucial role in the development and progression of various cancers.
  • Understanding these exosomal communications is vital for developing new cancer therapies and diagnostics.

Purpose of the Study:

  • To investigate the multifaceted role of exosomal non-coding RNAs in cell-to-cell communication within different sarcoma subtypes.
  • To consolidate current knowledge on exosome-mediated signaling in rare and heterogeneous sarcoma cancers.

Main Methods:

  • Systematic literature review and analysis of scientific publications.
  • Focus on studies detailing exosomal non-coding RNA cargo and their function in sarcoma.

Main Results:

  • Exosomal non-coding RNAs are significant mediators of intercellular communication in sarcoma.
  • The heterogeneity of sarcoma influences the specific roles of exosomal non-coding RNAs.
  • Evidence suggests potential for exosomal non-coding RNAs in sarcoma diagnosis and therapy.

Conclusions:

  • Exosomal non-coding RNAs are critical players in sarcoma progression and intercellular signaling.
  • Further research into exosome-based strategies holds promise for sarcoma treatment and diagnostics.
  • This review highlights the need for more studies on exosomal non-coding RNAs in diverse sarcoma subtypes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K